Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Stem Cell Mobilisation, Scar Reduction & Multi-System Repair (PubMed, 2012) A comprehensive review of TB4s biological properties confirmed it is released by platelets, macrophages, and multiple cell types following injury, where it protects tissues from further damage while reducing apoptosis, inflammation, and microbial growth
While not a cosmetic therapy, Dihexas ability to enhance mood, energy, and motivation can improve overall confidence and vitality
This short-chain tetrapeptide holds one of the most extensive peer-reviewed research profiles of any anti-aging compound, with studies spanning more than 35 years across in vitro, animal, and human observational models
Although it is not yet available, the manufacturer, Novo Nordisk, filed for FDA approval in December 2025, with FDA review expected in 2026
US$ 27.06
US$ 20.23
US$ 22.01
US$ 24.28
US$ 21.03
US$ 23.30
US$ 27.30
US$ 26.03
US$ 24.46
US$ 21.01
